State Street’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.02M Buy
988,367
+97,343
+11% +$816K ﹤0.01% 2676
2025
Q4
$6.63M Buy
891,024
+14,590
+2% +$105K ﹤0.01% 2854
2025
Q3
$5.86M Sell
876,434
-7,662
-0.9% -$53.2K ﹤0.01% 2937
2025
Q2
$5.85M Sell
884,096
-24,547
-3% -$174K ﹤0.01% 2865
2025
Q1
$8.31M Sell
908,643
-78,552
-8% -$785K ﹤0.01% 2647
2024
Q4
$10.4M Buy
987,195
+310,694
+46% +$3.67M ﹤0.01% 2616
2024
Q3
$8.08M Buy
676,501
+189,216
+39% +$1.64M ﹤0.01% 2732
2024
Q2
$2.8M Buy
487,285
+376,091
+338% +$2.06M ﹤0.01% 3180
2024
Q1
$578K Hold
111,194
﹤0.01% 3608
2023
Q4
$586K Hold
111,194
﹤0.01% 3607
2023
Q3
$367K Hold
111,194
﹤0.01% 3739
2023
Q2
$321K Sell
111,194
-430,264
-79% -$826K ﹤0.01% 3844
2023
Q1
$579K Sell
541,458
-26,601
-5% -$50.9K ﹤0.01% 3694
2022
Q4
$1.48M Buy
568,059
+70,081
+14% +$306K ﹤0.01% 3463
2022
Q3
$3.49M Sell
497,978
-11,491
-2% -$90K ﹤0.01% 3234
2022
Q2
$3.48M Buy
509,469
+80,685
+19% +$823K ﹤0.01% 3274
2022
Q1
$6.05M Buy
428,784
+35,248
+9% +$472K ﹤0.01% 3092
2021
Q4
$5.7M Buy
393,536
+244,638
+164% +$3.48M ﹤0.01% 3177
2021
Q3
$2.11M Buy
148,898
+16,399
+12% +$252K ﹤0.01% 3599
2021
Q2
$2.33M Buy
132,499
+69,456
+110% +$1.12M ﹤0.01% 3520
2021
Q1
$963K Buy
+63,043
New +$898K ﹤0.01% 3631

Other funds holding BVS